References
T. Andersson,Drugs,32(1), 15–47 (1986).
T. Andersson, C. Cederberg, and A. Heggelung,Drug Investigation,3(1), 45–52 (1991).
A. I. Tentsova and I. S. Azhgikhin,Medicinal Forms and Therapeutic Efficacy of Drugs [in Russian], Meditsina, Moscow (1974), pp. 302–320.
A. I. Tentsova, A. A. Litvin, and G. S. Kiseleva,Farmatsiya, No. 3, 26–29 (1986).
L. Z. Benet and R. L. Galeazzi,J. Pharm. Sci.,68, 537–550 (1979).
D. Brockmeier and H. M. Hattingberg,Drug. Res.,32, 248–252 (1982).
E. Dakkuri,Pharm. Techn.,6, 28–46 (1982).
F. Langenbucher,J. Pharm. Pharmacol.,24, 979–981 (1979).
T. Andersson,Clin. Pharmacokinetica,31, 9–28 (1996).
V. F. Okhotnikova and L. K. Grakovskaya,Review Inform., Sc. Chem.-Pharm. Ind. [in Russian], Central Libr. Sci.-Technol. I form. Med. Ind., Moscow (1979), No. 10, pp. 24–29.
V. N. Solov'ev, A. A. Firsov, and V. A. Yakovlev,Pharmaco inetics [in Russian], Meditsina, Moscow (1980), pp. 234–24
A. A. Firsov and V. K. Piotrovskii,Developments Sci. Techno Pharmacol., Chemotherap. Medicinals [in Russian], Moscc (1984), pp. 114–224.
V. K. Piotrovskii,Method of Individualization and Optimization of Drugs Based on Study of Their Pharmacokinetics [in Russian], Moscow (1982), pp. 79–82.
V. K. Piotrovskii,Khim.-Farm. Zh.,18(12), 1425–14 (1984).
V. K. Piotrovskii,Khim.-Farm. Zh.,18(7), 845–849 (1984).
L. E. Kholodov ad V. P. Yakovlev,Clinical Pharmacokinet, [in Russian], Meditsina, Moscow (1985), pp. 123–140.
F. Treiber, S. Walker, and U. Klotz,Clin. Pharmacol. The. 55(5), 486–491 (1994).
C. W. Hewden,Europ. J. Clin. Pharm.,26, 641–643 (1984).
R. T. Sane, J. K. Ghadge, A. B. Jani, et al.,Indian Dru 29(10), 445–446 (1992).
I. Aoki, M. Okumura, and T. Yashiki,J. Chromatography,5 283–290 (1991).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 32, No. 12, pp. 3–6, December, 1998.
Rights and permissions
About this article
Cite this article
Nikiforova, O.V., Arzamastsev, A.P. & Kruchenkov, A.A. Comparative analysis of the pharmaceutical accessibility of omeprazole in capsules from various manufacturers. Pharm Chem J 32, 625–628 (1998). https://doi.org/10.1007/BF02641310
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02641310